Patient preferences can help us to inform the weighting of different outcomes against each other.
In questions like “How much more efficacy is needed to outweight tolerability issues?” preferences by patients or other stakeholders could play a key role in quantitative benefit-risk assessments.
The 1-hour webinar takes place on October 24th at 4pm CET, 3pm UK time, and 10am ET in the US.
There will be lots of time for discussions after the presentation.
Kevin Marsh will speak in our webinar about
Do patient preference have a role in Health Technology Assessment? Current practice and future potential
Abstract: Both regulators and payers are actively exploring how they might use quantitative estimates of patient preferences to support their decisions. This is evident in initiatives such as IMI PREFER.